 | Mayer, Brown, Rowe & Maw named law firm of the year for pharmaceutical and medical devices law by JUVE
6 November 2006 - International law firm Mayer, Brown, Rowe & Maw LLP has been named "Law Firm of the Year in the field of pharmaceutical and medical devices law" by JUVE, the leading publisher in the German legal market. The firm was presented with the award at the annual JUVE awards ceremony, held in Frankfurt on November 2, 2006. Read >>
| | | 134 Mayer, Brown, Rowe & Maw Lawyers Listed in Chambers USA Guide to Leading Business Lawyers
6 June 2006 - One hundred thirty-four Mayer, Brown, Rowe & Maw LLP lawyers are listed in the 2006 Chambers USA guide to leading business lawyers. The guide highlights the firm's work in several dozen practice areas throughout the U.S. Mayer, Brown, Rowe & Maw LLP senior counsel Philip Lacovara and partner Robert Baptista were also singled out in receiving prestigious "Chambers USA Awards for Excellence." Read >>
| |  | Strengthening Pharmaceutical and Biotechnology Patents
01 March 2005 - All innovative companies recognize the vital interest they have in obtaining patents to protect their intellectual property. However, many companies do not realize that filing a patent application and securing a patent are only the first steps toward the effective protection of intellectual property. A recent court decision has shown that patent owners can also take proactive steps to strengthen their patents and make them less vulnerable to legal challenges after the patents have issued. Read >>
(A version of this article first appeared in Genetic Engineering News, Volume 25, Number 5, March 1, 2005.) | | | Sheila Dearybury Walcoff Appointed Associate FDA Commissioner for External Relations
7 September 2004 - Dr. Lester M. Crawford, Acting Food and Drug Administration Commissioner, today announced the appointment of Sheila Dearybury Walcoff, Esq., as the new FDA Associate Commissioner for External Relations. Ms. Walcoff is an attorney with extensive legal, strategic, and legislative experience in FDA-related areas. Read >>
| | | Biotech, Pharma and Life Science Newsletter
June 2004 - Federal Health Policy - Heard on Capitol Hill; Reform of European Pharmaceutical Legislation; FDA and SEC Join Forces on Misleading Progress
Claims by Pharmas; FDA Issues Final Rule Requiring Bar Codes; Impact of the New Rules for Technology Licences in Europe; Changes in R&D Tax Credits in the U.K.; U.K. University Victorious in R&D Copyright Case; European Commission Working Paper on Genetic Data; FTC and U.S. Courts Raise Questions About Legality of Pharmaceutical Patent Suit Settlements Read >>
| | | Debate Over "Generic Biologics" Poses Unique Challenges For Policy
14 May 2004 - Once again, the cost of pharmaceuticals is occupying the attention of the public, the press, and the U.S. Government. The politics of the situation are sufficiently strange that states are establishing websites which instruct their citizens on how to "re-import" prescription drugs from Canada, an act which is clearly illegal under current law and which Food and Drug Administration (FDA) Chief Counsel Dan Troy recently characterized as smuggling. Read >>
Copyright ¸ 2004 Washington Legal Foundation | | | Six Intellectual Property Lawyers Join Mayer, Brown, Rowe & Maw LLP in Washington, D.C.
26 April 2004, Washington, D.C. - Mayer, Brown, Rowe & Maw LLP announced today the addition of six intellectual property lawyers who previously acted as Pillsbury Winthrop's life sciences group. Read >>
| |
|
